Skip directly to content

Individualized Therapy for Non-Small Cell Lung Cancer

Non-small cell lung cancer represents about 85% of primary malignant tumors in the lung, yet some barriers still exist which may impede diagnosis and treatment. Discovery Channel CME has assembled a panel of key opinion leaders to discuss emerging and individualized therapies for patients with non-small cell lung cancer. The program addresses topics including appropriate first- line chemotherapeutic regimens, how to manage patients for whom first-line treatment has failed, as well as the role of biomarkers for the selection of targeted therapies. Differences in outcomes among minority patients are also discussed, with an emphasis on strategies to overcome challenges to treatment.